Gastroenterology - Increasing your risk of IBD through processed food
Can't see this email? View it online
   
  Gastroenterologyā€ˇ  
  The latest gastroenterologyā€ˇ news from News Medical  
 

Debilitating gastrointestinal symptoms could be controlled with diet and lifestyle modificationsMSI Testing Offers CRC Patients Life-saving Lynch Syndrome Detection

MSI-PCR and/or IHC is recommended for colorectal cancer (CRC) screening to help identify the most common form of hereditary CRC, Lynch syndrome. MSI is a recognized biomarker for the deficiencies in DNA mismatch repair caused by germline mutations. Knowing Lynch status can help patients and healthcare professionals make informed decisions.

Learn about MSI and Lynch syndrome testing
 
   Increasing your risk of IBD through processed foodIncreasing your risk of IBD through processed food
 
In this interview, News-Medical speaks to Dr. Neeraj Narula about ultra-processed food and how this can increase your risk of developing inflammatory bowel disease(IBD).
 
   Newly identified genetic mutation causes rare, early onset inflammatory bowel diseaseNewly identified genetic mutation causes rare, early onset inflammatory bowel disease
 
Johns Hopkins Medicine researchers, in collaboration with national and international researchers, have identified a genetic mutation in a small number of children with a rare type of inflammatory bowel disease.
 
 HMGA1 plays role in gastric cancer cell proliferation and metastasis
 
HMGA1 plays role in gastric cancer cell proliferation and metastasisAging-US published "HMGA1 promotes gastric cancer growth and metastasis by transactivating SUZ12 and CCDC43 expression" which reported that HMGA1 is overexpressed in GC cells and the high expression of HMGA1 was correlated with worse survival in GC patients using a bioinformatics assay.
 
 
 Study finds the link between circular RNA and alternative splicing in gastric cancer
 
Study finds the link between circular RNA and alternative splicing in gastric cancerAt the Chinese Academy of Sciences, scientists have now come up with a mechanism used by circular RNA to inhibit the metastasis of gastric cancer cells.
 
 
 Two studies on gastrointestinal stroma tumors describe advances that may lead to new treatments
 
Two studies on gastrointestinal stroma tumors describe advances that may lead to new treatmentsGastrointestinal stroma tumors (GIST) are cancers that start in specialized nerve cells found in the digestive system, from the esophagus and stomach to the intestines and rectum.